Agenus reports fourth quarter and full year 2022 financial results and outlines 2023 objectives

Lexington, mass., march 14, 2023 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with a pipeline of immunological agents targeting cancer and infectious disease, today provided a corporate update and reported financial results for the fourth quarter and full year 2022.
AGEN Ratings Summary
AGEN Quant Ranking